Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBL-514 in Dercum's Disease Lipomas
NCT05387733Phase 2Completed
- Sponsor
- Caliway Biopharmaceuticals
- Start
- Oct 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CBL-514 in Dercum's disease, sponsored by Caliway Biopharmaceuticals. Started Oct 2022; status: completed.
02
Drugs
CBL-514
03
Conditions
Dercum's disease
Beyond the preview
Go deeper on NCT05387733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05387733.